GF Fund Management’s Wave Life Sciences WVE Stock Holding History

GF Fund Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2K	Buy	3,985 +231	+6%	+$1.53K	﹤0.01%	470
2026 Q1	$27.2K	Buy	3,754 +469	+14%	+$6.11K	﹤0.01%	467
2025 Q4	$55.8K	Sell	3,285 -139	-4%	-$1.41K	﹤0.01%	398
2025 Q3	$25.1K	Sell	3,424 -481	-12%	-$3.89K	﹤0.01%	463
2025 Q2	$25.4K	Hold	3,905	–	–	﹤0.01%	476
2025 Q1	$31.6K	Buy	3,905 +703	+22%	+$7.69K	﹤0.01%	453
2024 Q4	$39.6K	Buy	+3,202	New	+$42.7K	﹤0.01%	415

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

GF Fund Management's WVE Position: Q2 2026 in Review

GF Fund Management increased its Wave Life Sciences (WVE) stake by 6.2% in Q2 2026, buying an estimated $1.53K and bringing the position to 3,985 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #470.

GF Fund Management first reported a position in WVE in Q4 2024 and has held it in 7 quarters since. The position peaked at $55.8K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

GF Fund Management held 3,985 shares of Wave Life Sciences worth $23.2K as of Q2 2026.
GF Fund Management bought 231 Wave Life Sciences shares in Q2 2026, an estimated $1.53K.
Wave Life Sciences made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #470 holding.
GF Fund Management first reported a position in Wave Life Sciences in Q4 2024 and has held it in 7 quarters since.
GF Fund Management's Wave Life Sciences position peaked at $55.8K in Q4 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.